UPSTREAM BIO, INC. Proceeds from Issuance or Sale of Equity
UPSTREAM BIO, INC. (UPB) reported Proceeds from Issuance or Sale of Equity of $670.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2026-08-11
- UPSTREAM BIO, INC. proceeds from issuance or sale of equity for the quarter ending 2026-06-30 was $2.10M.
- UPSTREAM BIO, INC. proceeds from issuance or sale of equity for the quarter ending 2026-03-31 was $668.80M.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month |
|---|---|---|
| 2026-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $670.90M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $668.80M 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |